OMNICARE PHARMACY LIMITED

Active Edinburgh

Other business support service activities n.e.c.

207 employees website.com
Other business support service activities n.e.c.
O

OMNICARE PHARMACY LIMITED

Other business support service activities n.e.c.

Founded 8 Oct 2003 Active Edinburgh, United Kingdom 207 employees website.com
Other business support service activities n.e.c.

Previous Company Names

ORCHARD INCORPORATIONS (61S) LIMITED 8 Oct 2003 — 31 Oct 2003
Accounts Submitted 4 Sept 2025 Next due 30 Jun 2026 1 month remaining
Confirmation Submitted 19 Mar 2026 Next due 20 Mar 2027 10 months remaining
Net assets £2M £94K 2023 year on year
Total assets £15M £206K 2023 year on year
Total Liabilities £14M £300K 2023 year on year
Charges 5
1 outstanding 4 satisfied

Contact & Details

Contact

Registered Address

5 Coalhill Leith Edinburgh EH6 6RH United Kingdom

Telephone

0800 000 0000

Website

www.example.com

Full company profile for OMNICARE PHARMACY LIMITED (SC257251), an active company based in Edinburgh, United Kingdom. Incorporated 8 Oct 2003. Other business support service activities n.e.c.. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2023
Type Total Exemption Full
Next accounts 31 December 2024
Due by 30 September 2025 9 months

Balance Sheet & P&L (2014–2023)

Cash in Bank

£3.15M

Increased by £875.72k (+38%)

Net Assets

£1.72M

Increased by £94.05k (+6%)

Total Liabilities

£13.72M

Decreased by £300.15k (-2%)

Turnover

£25.95M

Increased by £2.98M (+13%)

Employees

207

Increased by 4 (+2%)

Debt Ratio

89%

Decreased by 1 (-1%)

Financial History

Revenue, profit, EBITDA and key financial figures

2023
Dec Year End
2022
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

Officers

0 active 3 resigned
Status

No officers found

No officers found

Shareholders

Shareholders (14)

Christopher James Freeland
18.9%
2,500
Lois Freeland
18.9%
2,500

Persons with Significant Control

Persons with Significant Control (0)

No PSC information available

Group Structure

Group Structure

OMNICARE PHARMACY LIMITED Current Company
C BUCHANAN LIMITED united kingdom
J M PHARMA LIMITED united kingdom
PRIVATEDOC LIMITED united kingdom

Charges

Charges

1 outstanding 4 satisfied

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
19 Mar 2026Confirmation StatementConfirmation statement made on 6 Mar 2026 with updates
3 Dec 2025OfficersTermination of George Keith Freeland as director on 1 Oct 2025
3 Dec 2025OfficersTermination of George Keith Freeland as director on 1 Oct 2025
12 Nov 2025CapitalCapital Return Purchase Own Shares
12 Nov 2025CapitalCapital Return Purchase Own Shares
19 Mar 2026 Confirmation Statement

Confirmation statement made on 6 Mar 2026 with updates

3 Dec 2025 Officers

Termination of George Keith Freeland as director on 1 Oct 2025

3 Dec 2025 Officers

Termination of George Keith Freeland as director on 1 Oct 2025

12 Nov 2025 Capital

Capital Return Purchase Own Shares

12 Nov 2025 Capital

Capital Return Purchase Own Shares

Recent Activity

Latest Activity

Confirmation statement made on 6 Mar 2026 with updates

1 months ago on 19 Mar 2026

Termination of George Keith Freeland as director on 1 Oct 2025

5 months ago on 3 Dec 2025

Termination of George Keith Freeland as director on 1 Oct 2025

5 months ago on 3 Dec 2025

Capital Return Purchase Own Shares

6 months ago on 12 Nov 2025

Capital Return Purchase Own Shares

6 months ago on 12 Nov 2025